N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives-Reference-Cited by-同舟云学术

N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives

Published:2020-12 Issue: Volume:182 Page:114258
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Xu Zhijie,Peng Bi^ORCID,Cai Yuan^ORCID,Wu Geting^ORCID,Huang Jinzhou,Gao Ming,Guo Guijie,Zeng Shuangshuang^ORCID,Gong Zhicheng^ORCID,Yan Yuanliang^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference193 articles.

1. Telomere length and cancer mortality in American Indians: The Strong Heart Study;Subedi;GeroScience,2019

2. Role of non-coding RNAs and RNA modifiers in cancer therapy resistance;Zhang;Mole. Cancer,2020

3. Tumour heterogeneity and resistance to cancer therapies, Nature reviews;Dagogo-Jack;Clin. Oncol.,2018

4. m(6)A modification in coding and non-coding RNAs: Roles and therapeutic implications in cancer;Huang;Cancer cell,2020

5. The interplay between m6A RNA methylation and noncoding RNA in cancer;Ma;J. Hematol. Oncol.,2019

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Writers, readers, and erasers RNA modifications and drug resistance in cancer;Molecular Cancer;2024-08-30

2. 20(R)-Panaxatriol enhances METTL3-mediated m6A modification of STUB1 to inhibit autophagy and exert antitumor effects in Triple-Negative Breast Cancer cells;Phytomedicine;2024-07

3. Regulations of m6A and other RNA modifications and their roles in cancer;Frontiers of Medicine;2024-06-22

4. Changes of RNA m6A/m5C Modification Regulatory Molecules in Ferroptosis of T2DM Rat Pancreas;Cell Biochemistry and Biophysics;2024-05-06

5. RNA modifications in pulmonary diseases;MedComm;2024-05